Related Experiment Video
Updated: Jul 9, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Atrial fibrillation and marijuana smoking
P Korantzopoulos1, T Liu, D Papaioannides
1Department of Cardiology, University of Ioannina Medical School, Ioannina, Greece. p.korantzopoulos@yahoo.gr
International Journal of Clinical Practice
|November 23, 2007
Summary
Marijuana smoking may trigger atrial fibrillation (AF) in susceptible individuals. This review examines case reports and discusses potential mechanisms linking cannabis use to this heart rhythm disorder.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Marijuana is a widely used illicit substance with increasing prevalence of abuse.
- Cannabis use can impact the cardiovascular system, leading to various adverse events.
- Emerging evidence suggests a potential link between marijuana smoking and atrial fibrillation (AF).
Purpose of the Study:
- To systematically review reported cases of atrial fibrillation (AF) associated with marijuana smoking.
- To explore the potential pathophysiological mechanisms underlying this association.
- To discuss the clinical implications of marijuana-induced AF.
Main Methods:
- Systematic literature search for case reports and studies on marijuana use and AF.
- Analysis of reported cases to identify common characteristics and outcomes.
- Review of existing literature on the cardiovascular effects of cannabinoids.
Main Results:
- Compilation of case reports demonstrating a temporal association between marijuana smoking and AF onset.
- Identification of potential mechanisms including direct electrophysiological effects and sympathomimetic actions.
- Discussion of clinical scenarios where marijuana use may precipitate AF.
Conclusions:
- Marijuana smoking is increasingly implicated as a potential trigger for atrial fibrillation (AF).
- Understanding the underlying mechanisms is crucial for managing patients with cannabis use and cardiac arrhythmias.
- Further research is warranted to confirm causality and guide clinical practice regarding marijuana and cardiovascular health.
Related Concept Videos
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
01:29Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
01:28Dysrhythmias II: Classification of Tachyarrhythmias
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...